AFFINIA THERAPEUTICS
Affinia Therapeutics is a developer of a platform for rationally designed adeno-associated virus (AAV) vectors and gene therapies intended to develop medicines for devastating diseases. The company leverages synthetic and systems biology combined with high-throughput screening and tissue and single-cell resolution for people affected by muscle and central nervous system (CNS) diseases with significant unmet needs, thereby providing medical professionals with the rational design of novel vectors and gene therapies with remarkably improved properties.
AFFINIA THERAPEUTICS
Industry:
Biotechnology Health Care Life Science Therapeutics
Founded:
2019-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.affiniatx.com
Total Employee:
51+
Status:
Active
Contact:
617-430-7817
Total Funding:
170 M USD
Technology used in webpage:
Google Maps U.S. Server Location Google Maps API Microsoft Microsoft Azure Google Maps For Work Microsoft Azure US East Region
Similar Organizations
Areteia Therapeutics
Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease.
Artiva Biotherapeutics
Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Design Therapeutics
Design Therapeutics is a biotechnology company developing a new class of therapies for serious degenerative disorders.
Freeline
Freeline Therapeutics is a biotechnology company focused on developing liver directed gene therapies for a range of diseases.
Mythic Therapeutics
Mythic Therapeutics is a biotechnology company focused on a new generation of groundbreaking cancer therapeutics.
Prevail Therapeutics
Prevail Therapeutics is a biotechnology company focused on developing novel gene therapies for patients with Parkinson’s disease.
Rallybio
Rallybio is an biotechnological research and development services intended to transform the lives of patients with a devastating disease.
SalioGen Therapeutics
SalioGen Therapeutics is a gene coding company that develops potentially curative therapies for patients with inherited disorders.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Board_member
2020-03-01
Board_member
2020-03-01
Board_member
2020-02-01
Board_member
2021-05-01
Board_member
2019-10-01
Board_member
2020-03-01
Current Employees Featured
Rob Aboud Co-Founder and CLO @ Affinia Therapeutics
Co-Founder and CLO
Thomas Leggett Cheif Finacial Officer @ Affinia Therapeutics
Cheif Finacial Officer
2021-12-01
Gregg Davis Vice President of Corporate Development @ Affinia Therapeutics
Vice President of Corporate Development
2022-02-01
Rick Modi Chief executive officer @ Affinia Therapeutics
Chief executive officer
2019-08-01
Botond Roska Co-Founder and Scientific Adviser @ Affinia Therapeutics
Co-Founder and Scientific Adviser
2019-01-01
Robert Johnson Co-Founder and Head of Business Development and Licensing @ Affinia Therapeutics
Co-Founder and Head of Business Development and Licensing
2020-10-01
Luk Vandenberghe Scientific Founder & Board Member @ Affinia Therapeutics
Scientific Founder & Board Member
2019-02-01
Petra Kaufmann Chief Medical Officer @ Affinia Therapeutics
Chief Medical Officer
2021-02-01
Amitabha Deb Vice President, Head of Process Sciences @ Affinia Therapeutics
Vice President, Head of Process Sciences
2020-12-01
Charles Albright Chief Scientific Officer @ Affinia Therapeutics
Chief Scientific Officer
Founder
Investors List
Woodline Partners
Woodline Partners investment in Series B - Affinia Therapeutics
TCG Crossover
TCG Crossover investment in Series B - Affinia Therapeutics
Octagon Capital Advisors
Octagon Capital Advisors investment in Series B - Affinia Therapeutics
Atlas Venture
Atlas Venture investment in Series B - Affinia Therapeutics
Farallon Capital Management
Farallon Capital Management investment in Series B - Affinia Therapeutics
Casdin Capital
Casdin Capital investment in Series B - Affinia Therapeutics
Perceptive Advisors
Perceptive Advisors investment in Series B - Affinia Therapeutics
Lonza
Lonza investment in Series B - Affinia Therapeutics
Google Ventures
Google Ventures investment in Series B - Affinia Therapeutics
F-Prime Capital
F-Prime Capital investment in Series B - Affinia Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-12-14 | Affinia Therapeutics Appoints Thomas Leggett as Chief Financial Officer |
Official Site Inspections
http://www.affiniatx.com Semrush global rank: 4.97 M Semrush visits lastest month: 1.69 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Affinia Therapeutics"
Affinia Therapeutics - Crunchbase Company Profile
Organization. Affinia Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ...See details»
Affini-T Therapeutics | Unlocking the power of T cells
11.06.2024. Affini-T Therapeutics to Present Trial-in-Progress Poster and Preclinical Data from Its Oncogenic Driver Programs Targeting TP53 R175H, KRAS G12D and KRAS-G12V at the …See details»
Affinia Therapeutics - Overview, News & Similar companies
Affinia Therapeutics contact info: Phone number: (617) 430-7817 Website: www.affiniatx.com What does Affinia Therapeutics do? Founded in 2019, Affinia Therapeutics is a preclinical …See details»
Affinia Therapeutics and Forge Biologics Announce AAV cGMP ...
Nov 13, 2024 For more information, visit https://www.affiniatx.com. About Forge Biologics. Forge Biologics, a member of Ajinomoto Bio-Pharma Services, is a hybrid gene therapy contract …See details»
Affinia Therapeutics - Company Profile & Staff Directory
Affinia Therapeutics is a Biotechnology company located in 43 Foundry, Ste 120, Waltham, Massachusetts 02453, US with 83 employees. Access Affinia Therapeutics's email format and …See details»
Affinia Therapeutics - VentureRadar
"Affinia Therapeutics is pioneering a shift to a new class of rationally-designed gene therapies that treat rare and prevalent diseases. Affinia Therapeutics’ proprietary Affinia Rationally- designed …See details»
Working At Affinia Therapeutics: Company Overview and Culture
Mar 14, 2024 affiniatx.com. Organization Type. Private. CEO. Rick Modi. Affinia Therapeutics is a small company based in Waltham, MA with only 75 employees and an annual revenue of …See details»
Affinia Therapeutics Inc. - Life-Sciences-Europe.com
Feb 27, 2019 BIO (US) (Biotechnology Innovation Organization, formerly Biotechnology Industry Organization) EuropaBio aisbl – the European Association of Bioindustries; BioIndustry …See details»
Affinia Therapeutics Company Overview, Contact Details
Ecor1cap invested into Affinia Therapeutics, Inc. $110M on May 3rd '21. Affinia Therapeutics, an innovative gene therapy company with a proprietary platform for rationally designed adeno …See details»
Affinia Therapeutics - Craft
Affinia Therapeutics has 5 employees at their 1 location and $60 m in total funding,. See insights on Affinia Therapeutics including office locations, competitors, revenue, financials, executives, …See details»
Affini-T Therapeutics - Overview, News & Similar companies
Jun 1, 2024 Who is Affini-T Therapeutics. Affini-T Therapeutics is a company that specializes in leveraging synthetic biology and gene editing technologies, allowing teams to overcome key h …See details»
Affinia Therapeutics - LinkedIn
Affinia Therapeutics is excited to announce the appointment of Hideo Makimura, MD, PhD as its Chief Medical Officer.Hideo is a seasoned physician-scientist and biopharmaceutical R&D …See details»
Affinia Therapeutics - Products, Competitors, Financials, Employees ...
Affinia Therapeutics specializes in the development of adeno-associated virus (AAV) gene therapies within the biopharmaceutical sector. Use the CB Insights Platform to explore Affinia …See details»
Affinia Therapeutics - Work in biotech
Affinia Therapeutics is enhancing gene therapies by expanding the potential of adeno-associated viruses (AAVs). AAVs are the vectors that target cells and deliver gene therapies. Affinia is …See details»
Affinia Therapeutics - Employees, Contact info, Overview - Wiza
Apr 30, 2024 View info about Affinia Therapeutics (affiniatx.com). Affinia Therapeutics is a company located in Waltham, Massachusetts, United States. Find employees, official website, …See details»
Affinia Therapeutics Announces Addition of Gene Therapy
Feb 17, 2021 -- Gene editing expert Charles Albright, Ph.D., joins as chief scientific officer -- -- Gene therapy development expert Petra Kaufmann, M.D., joins as...See details»
Affinia Therapeutics Strengthens Leadership Team with
WALTHAM, Mass., March 08, 2022 (GLOBE NEWSWIRE) -- Affinia Therapeutics, an innovative gene therapy company with a proprietary platform for...See details»
Affinia Therapeutics Presents Preclinical Data for Genetic ...
May 10, 2024 Novel cardiotropic capsids transduce more than 90% of cardiomyocytes in non-human primates (NHPs) and detarget the liver and dorsal root ganglia (DRG); show safety and …See details»
Affinia Therapeutics to Present Preclinical Data on Novel AAV …
WALTHAM, Mass., Oct. 24, 2023 /PRNewswire/ -- Affinia Therapeutics ("Affinia"), an innovative gene therapy company with a proprietary platform for rationally designed adeno-associated …See details»
AffiniaTx - GitHub
Saved searches Use saved searches to filter your results more quicklySee details»